ArticleFrontiers in pharmacology2025
Phylogeny, ethnomedicinal use and the distribution of phytoestrogens in the Fabaceae.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Phytoestrogens, with estrogenic activity, are commonly found across the Fabaceae family. Here we develop methods that use phylogeny and ethnomedicinal information in order to identify candidate species for novel phytoestrogens. Method: We selected Fabaceae species traditionally used as aphrodisiacs or with applications to control fertility (aphrodisiac-fertility species), to create a cross-cultural dataset of ethnomedicinal use. Using a phylogeny of the Fabaceae, "hot nodes" methods were used to identify lineages with a higher number of species with aphrodisiac-fertility uses. The known distribution of estrogenic flavonoids was used to determine whether the phytoestrogen-containing species was associated with aphrodisiac-fertility "hot nodes". Additionally, we examined the overlap of aphrodisiac-fertility uses with neurological applications, hypothesising that such species may have bioactive compounds with estrogenic properties. Lastly, the "aphrodisiac-fertility hot node" lineages without previously known estrogenic flavonoids were identified. Results: We showed species in aphrodisiac-fertility hot nodes were more likely to contain estrogenic flavonoids (21% of species), a major group of phytoestrogens, compared to Fabaceae in the phylogeny (11% of species). Additionally, when aphrodisiac fertility species are limited to those with neurological applications, 62% of the species within hot nodes contain estrogenic flavonoids. Discussion: We recognised 43 high-priority hot nodes, these lineages might represent promising targets for future studies on phytoestrogens. The results demonstrated the combining phylogenetic and ethnomedicinal data to guide the discovery of estrogenic flavonoids with therapeutic potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.